ClinicalTrials.gov
ClinicalTrials.gov Menu

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01368757
Recruitment Status : Unknown
Verified March 2015 by Arbeitsgemeinschaft medikamentoese Tumortherapie.
Recruitment status was:  Active, not recruiting
First Posted : June 8, 2011
Last Update Posted : March 9, 2015
Sponsor:
Collaborator:
Celgene Corporation
Information provided by:
Arbeitsgemeinschaft medikamentoese Tumortherapie

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : May 2015
  Estimated Study Completion Date : May 2015